Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 50.86B | 53.11B | 59.54B | 67.23B | 59.15B | 41.40B |
Gross Profit | 3.19B | 3.39B | 4.84B | 3.68B | 3.36B | 2.79B |
EBITDA | 2.64B | 2.46B | 4.02B | 2.88B | 3.23B | 2.11B |
Net Income | 1.38B | 1.14B | 2.24B | 1.61B | 2.08B | 1.15B |
Balance Sheet | ||||||
Total Assets | 31.15B | 24.90B | 25.37B | 24.58B | 23.82B | 23.66B |
Cash, Cash Equivalents and Short-Term Investments | 7.14B | 3.79B | 2.71B | 1.22B | 1.42B | 698.00M |
Total Debt | 12.21B | 7.12B | 5.76B | 5.62B | 6.82B | 8.10B |
Total Liabilities | 19.20B | 13.95B | 13.56B | 14.62B | 15.61B | 17.04B |
Stockholders Equity | 10.88B | 9.91B | 10.85B | 9.22B | 7.67B | 6.07B |
Cash Flow | ||||||
Free Cash Flow | 180.00M | 524.00M | 2.19B | -6.10B | -3.29B | -3.90B |
Operating Cash Flow | 1.02B | 1.90B | 3.31B | -5.55B | -2.89B | -3.54B |
Investing Cash Flow | -668.00M | -1.11B | -1.01B | 6.50B | 5.11B | 1.81B |
Financing Cash Flow | 5.24B | -90.00M | -856.00M | -769.00M | -1.63B | 1.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | $5.48B | 4.43 | 55.96% | 7.36% | 83.19% | 339.22% | |
77 Outperform | $29.81B | 27.31 | 4.93% | 3.28% | -6.70% | -54.38% | |
77 Outperform | $16.29B | 8.13 | 13.20% | 3.40% | -8.87% | 13.21% | |
76 Outperform | $1.71B | 11.57 | 7.49% | 3.20% | 1.41% | ― | |
71 Outperform | $10.03B | ― | 3.09% | ― | ― | ||
66 Neutral | $19.72B | 25.13 | 4.31% | 3.56% | 1.99% | ― | |
63 Neutral | $20.50B | 14.76 | -2.72% | 3.09% | 1.90% | -4.74% |
On July 31, 2025, Bunge Limited Finance Corp., a subsidiary of Bunge Global SA, completed the sale and issuance of $1.3 billion in senior notes, divided into two tranches due in 2030 and 2035. The proceeds from this offering, which was managed by several major financial institutions, are intended for general corporate purposes, including debt repayment and investments, potentially impacting Bunge’s financial flexibility and market positioning.
On July 8, 2025, Bunge Limited Finance Corp., a subsidiary of Bunge Global SA, completed its exchange offers and consent solicitations for various notes issued by Viterra Finance B.V. This involved exchanging existing Viterra notes for new Bunge notes and cash, and amending the terms of the existing notes to eliminate certain covenants and provisions. The completion of these offers resulted in the issuance of new notes with different interest rates and maturity dates, impacting Bunge’s financial operations and obligations. The remaining Viterra notes that were not exchanged will continue under the modified terms.
On July 7, 2025, Bunge Global SA announced the expiration and final results of its Exchange Offers and Consent Solicitations related to Viterra’s outstanding notes, following the completion of Bunge’s acquisition of Viterra on July 2, 2025. The Exchange Offers, which expired on July 3, 2025, involved exchanging Viterra’s notes for new notes issued by Bunge Limited Finance Corp. and cash, with sufficient consents received to amend existing indentures and release guarantees. The settlement is expected on July 8, 2025, marking a significant step in Bunge’s strategic integration of Viterra, potentially impacting its financial structure and market positioning.
On July 2, 2025, Bunge Global completed its merger with Viterra Limited, creating a premier global agribusiness solutions company. This strategic combination aims to enhance Bunge’s capabilities in connecting farmers to consumers, with a focus on meeting the evolving needs of customers and maximizing stakeholder value. The merger is expected to provide significant financial and operational benefits, including improved logistics, trading optionality, and a more stable cash flow profile. Additionally, the merger brings together experienced management teams to drive value creation and operational efficiency.
On June 13, 2025, Bunge, along with Glencore, CPPIB, and BCI, amended their Business Combination Agreement, setting the closing date for their transactions, including an acquisition, to July 2, 2025. The amendment also extended the outside date to July 3, 2025, and waived certain conditions for closing. Approvals were received from regulatory bodies in China and Mexico, satisfying antitrust and foreign investment laws, with the transactions expected to be completed on July 2, 2025.
On June 12, 2025, Bunge Global SA announced that its subsidiary, Bunge Limited Finance Corp., extended the expiration date for its exchange offers and consent solicitations related to Viterra Finance B.V.’s notes. This extension is part of Bunge’s pending acquisition of Viterra, with the expiration date moved to July 3, 2025, to accommodate the completion of the business combination. The extension aims to facilitate the exchange of existing notes for new Bunge notes and cash, while also amending certain indentures to eliminate covenants and modify provisions. The move is expected to impact the liquidity of Viterra’s existing notes and reduce protections for remaining holders.